Apotex settlement with indirect resellers in US generic drug suit gets final nod
MLex Summary: Indirect resellers’ $5.2 million settlement with Apotex to resolve US price-fixing claims over generic pharmaceuticals has been granted final approval by a federal judge.See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article